Anteris Technologies Global Corp. (AVR)
NASDAQ:AVR
Want to see AVR full AI Analyst Report?
AVR Stock Chart & Stats
$5.68
-$0.12(-2.09%)
At close: 4:00 PM EST
$5.68
-$0.12(-2.09%)
Day’s Range― - ―
52-Week Range$2.85 - $8.65
Previous Close$5.88
Volume157.53K
Average Volume (3M)151.40K
Market Cap
$839.09M
Enterprise Value$37.64M
Total Cash (Recent Filing)$283.21M
Total Debt (Recent Filing)$3.73M
Price to Earnings (P/E)―
Beta1.93
Next Earnings
Aug 17, 2026EPS Estimate
-0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.00
Shares Outstanding97,342,200
10 Day Avg. Volume215,658
30 Day Avg. Volume151,395
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)-1.27K
Price to Sales (P/S)61.50
P/FCF Ratio-1.48
Enterprise Value/Market Cap0.04
Enterprise Value/Revenue20.34
Enterprise Value/Gross Profit71.97
Enterprise Value/Ebitda-0.40
Forecast
1Y Price Target
$16.00Price Target Upside181.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)-1.15
Revenue Forecast (FY)$8.13M
Bulls Say, Bears Say
Bulls Say
Board Financial ExpertiseAdding a veteran finance executive to the board and reinforcing audit oversight strengthens governance and financial discipline. Over 2–6 months this improves capital allocation, audit rigor, and credibility with lenders/investors, reducing execution risk during capital raises or scaling.
Long-term Facility Lease And AbatementsA large, long‑term facility commitment supports operational scale-up and manufacturing capacity for heart valve products. Initial rent abatements ease near‑term cash flow pressure while the lease’s duration and extension options lock in capacity for commercialization and supply chain stability.
Improved Gross ProfitabilityStronger gross margins indicate favorable product economics or improved manufacturing cost control. If commercialization advances, sustained gross profitability provides leverage to cover operating costs as revenue scales, supporting a clearer path toward durable operating margin improvement.
Bears Say
Severe Persistent Cash BurnLarge, ongoing negative cash flows create continuous financing needs and elevate dilution and refinancing risk. Over several months this limits strategic flexibility, forces prioritization of projects, and could constrain commercialization if additional capital is not secured on acceptable terms.
Shrinking And Very Small Revenue BaseVery low and declining revenue versus a large cost base signals limited market traction and a long runway to scale. This structural revenue weakness makes it harder to absorb fixed costs, delaying sustainable profitability even if gross margins improve.
Uneven Balance-sheet History And Prior Negative EquityPrior negative equity and reporting volatility indicate past recapitalizations or losses that can complicate comparability and creditor confidence. This uneven history can raise cost of capital, create governance scrutiny, and increase the probability of dilutive financing during growth or cash shortfalls.
Anteris Technologies Global Corp. News
AVR FAQ
What was Anteris Technologies Global Corp.’s price range in the past 12 months?
Anteris Technologies Global Corp. lowest stock price was $2.85 and its highest was $8.64 in the past 12 months.
What is Anteris Technologies Global Corp.’s market cap?
Anteris Technologies Global Corp.’s market cap is $839.09M.
When is Anteris Technologies Global Corp.’s upcoming earnings report date?
Anteris Technologies Global Corp.’s upcoming earnings report date is Aug 17, 2026 which is in 87 days.
How were Anteris Technologies Global Corp.’s earnings last quarter?
Anteris Technologies Global Corp. released its earnings results on May 12, 2026. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of -$0.271 by -$0.009.
Is Anteris Technologies Global Corp. overvalued?
According to Wall Street analysts Anteris Technologies Global Corp.’s price is currently Undervalued.
Does Anteris Technologies Global Corp. pay dividends?
Anteris Technologies Global Corp. does not currently pay dividends.
What is Anteris Technologies Global Corp.’s EPS estimate?
Anteris Technologies Global Corp.’s EPS estimate is -0.22.
How many shares outstanding does Anteris Technologies Global Corp. have?
Anteris Technologies Global Corp. has 97,342,200 shares outstanding.
What happened to Anteris Technologies Global Corp.’s price movement after its last earnings report?
Anteris Technologies Global Corp. reported an EPS of -$0.28 in its last earnings report, missing expectations of -$0.271. Following the earnings report the stock price went down -2.537%.
Which hedge fund is a major shareholder of Anteris Technologies Global Corp.?
Currently, no hedge funds are holding shares in AVR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Anteris Technologies Global Corp. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.00 (181.69% Upside)
$16.00 (181.69% Upside)
Hedge Fund Trend
Decreased
By 29.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.3%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.53%
12-Months-Change
Fundamentals
Return on Equity
-124.39%
Trailing 12-Months
Asset Growth
401.30%
Trailing 12-Months
Company Description
Anteris Technologies Global Corp.
Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. was incorporated in 1999 and is based in Toowong, Australia.
AVR Stock 12 Month Forecast
Average Price Target
$16.00
▲(181.69% Upside)
Technical Analysis
Anika Therapeutics
―
Apyx Medical
―
Inogen
―
Treace Medical Concepts
―
Rapid Micro Biosystems
―
Ownership Overview
13.99% Insiders
4.51% Mutual Funds
44.76% Other Institutional Investors
32.26% Public Companies and
Individual Investors